Prospective Echocardiography Assessment of Pulmonary Hypertension and Its Potential Etiologies in Children With Sickle Cell Disease††Conflicts of Interest: Dr. Gordeuk Has Received Grants From BioMarin Pharmaceutical Inc., Novato, California, and Actelion Pharmaceuticals Ltd., Allschwil, Switzerland, and Is a Consultant for Ikaria Holdings, Clinton, New Jersey.

American Journal of Cardiology - United States
doi 10.1016/j.amjcard.2009.04.034
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pulmonary Hypertension in Sickle Cell Disease

New England Journal of Medicine
Medicine
2011English

Sildenafil Therapy in Patients With Sickle Cell Disease and Pulmonary Hypertension

British Journal of Haematology
Hematology
2005English

Relative Systemic Hypertension in Patients With Sickle Cell Disease Is Associated With Risk of Pulmonary Hypertension and Renal Insufficiency

American Journal of Hematology
Hematology
2007English

Severe Pulmonary Hypertension in an Adolescent With Sickle Cell Disease

American Journal of Hematology
Hematology
2007English

Pulmonary Complications and Lung Function Abnormalities in Children With Sickle Cell Disease

2016English

Coagulation Activation and Inflammation in Sickle Cell Disease-Associated Pulmonary Hypertension

Haematologica
Hematology
2008English

A Sickle Cell Disease Patient With Severe Tricuspid Regurgitation and Early Developed Pulmonary Hypertension

Internal Medicine
Internal MedicineMedicine
2015English

Assessment of Care of Children With Sickle Cell Disease.

BMJ
1990English

Endothelin Receptor Antagonists for Pulmonary Hypertension in Adult Patients With Sickle Cell Disease

British Journal of Haematology
Hematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy